Therefore, considering all data reported so far, we believe that analysis of three genes (KCNH2, KCNQ1, and KCNJ2) should be performed in all suspected cases of SQTS, followed by a comprehensive genetic interpretation of each rare variant identified before translation into clinical practice. The gene discussed is KCNJ2; the disease is Familial short QT syndrome.